What I-Mind does

BC Platforms is a privately held healthcare data and analytics company founded in 1997 and headquartered in Zurich, Switzerland. The company operates a global real-world data network spanning 35+ countries with access to 187M+ patient lives via 150+ data partners, and has supported 20+ FDA/EMA regulatory submissions over 25+ years of operating history. Its core product suite spans five integrated platforms: BC Unify (AI-driven data mastering), BC Catalyst (AI-powered cohort discovery and prompt-based precision medicine), BC Image (AI-driven medical image processing), BC Mosaic (trusted research environment for federated analytics with NVIDIA accelerated computing), and BC Data (the underlying global RWD network). The platform supports clinical development, regulatory submissions, biomarker research, and post-launch evidence generation across oncology, rare diseases, neurology, and other therapeutic areas.

BC Platforms generates revenue through three primary streams: subscription-based platform access to the BC product suite, data access and licensing for harmonized research-ready datasets, and professional services including scientific consulting, technology implementation, and custom evidence generation. Pricing is quote-based and subscription-oriented, with annual billing on enterprise contracts. The company has offices in Zurich (headquarters), Toulouse and Paris (via Medexprim), and Hyderabad (India operations), and serves customers including top 20 global pharmaceutical companies, NHS hospitals, academic medical centers, and government-led precision medicine programs. Distribution is via enterprise field sales, AWS Marketplace procurement, and a global data partner network, with strategic alliances with AWS and NVIDIA anchoring the technology stack.

Name

I-Mind

Legal name

BC Platforms AG

Website

https://i-mind.se

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

BC Platforms is a Swiss-headquartered healthcare data and analytics company that provides AI-powered platforms and a global real-world data network spanning 35+ countries and 187M+ patients, serving top 20 pharmaceutical companies, healthcare providers, and academic medical centers across clinical development and regulatory submissions.

Ownership category

akta.pro rank

Product category

Healthcare Data Analytics Platforms

NAICS

Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Scientific Research and Development Services (5417)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM)

Keywords

• Healthcare data analytics
• Real-world evidence platforms
• Trusted research environments
• Federated data network
• Precision medicine data

Headquarters

HQ city

Port St. Lucie

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Platform Software Subscriptions: BC Platforms generates revenue through subscription-based access to its AI-powered platforms (BC Unify, BC Catalyst, BC Mosaic, BC Image, BC Data). Customers access the platforms to harmonize data, build cohorts, run analytics, and generate real-world evidence.
2. Data Access and Licensing: Revenue from providing access to harmonized, research-ready datasets from the global data partner network spanning 187M+ patients. Includes data licensing fees and data provisioning services.
3. Scientific and Technology Consulting Services: Professional services revenue from consulting engagements including study strategy, data architecture, analytics and insights, evidence delivery, technology implementation, AI system validation, and custom development.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

BC Platforms provides AI-driven healthcare data analytics software platforms enabling life sciences companies and healthcare organizations to harmonize, secure, and analyze multi-modal patient data (clinical, genomic, imaging, real-world). Core products include BC Unify (data mastering), BC Catalyst (prompt-based precision medicine), BC Image (medical imaging), BC Mosaic (trusted research environment with federated analytics), and BC Data (global real-world data network with 187M+ patients across 35+ countries), complemented by Scientific & Technology Consulting and Real-World Evidence Generation services.

Product overview

BC Platforms is a multi-platform solution provider for healthcare data and analytics, featuring five core integrated products: BC Unify (AI-driven data mastering platform), BC Catalyst (AI-powered cohort discovery), BC Image (medical image processing), BC Mosaic (trusted research environment for federated analytics), and BC Data (global real-world data network with 187M+ patients). These products work together with BC Unify serving as the integration engine powering all solutions, BC Mosaic enabling secure federated access to harmonized data, and BC Data providing the underlying patient data assets. The company also offers Scientific & Technology Consulting services for evidence generation and technology implementation. The integrated platform supports clinical development, regulatory submissions, and precision medicine across 35+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• BC Unify: AI-driven, end-to-end data mastering platform that ingests, harmonizes, transforms, and enriches multi-modal data for advanced analytics and healthcare research.
• BC Catalyst
• BC Image
• BC Mosaic
• BC Data
• Scientific & Technology Consulting

Products and services

• BC Unify AI-driven, end-to-end data mastering platform that ingests, harmonizes, transforms, and enriches multi-modal data from diverse sources into research-ready datasets for life sciences and healthcare organizations.
• BC Catalyst AI-powered cohort building, biomarker discovery, and population health insights platform with a prompt-based interface that makes complex genomic and real-world clinical data actionable through natural language queries.
• BC Image AI-driven platform that automates image extraction, de-identification, and processing for medical images, with capacity to handle millions of images per week while remaining GDPR compliant.
• BC Mosaic Trusted research environment (TRE) for clinical, genomic, and multi-omics studies. AI-powered platform with federated architecture and NVIDIA accelerated computing, available on AWS Marketplace, enabling secure collaboration and analytics across distributed datasets.
• BC Data Global real-world data network spanning 35+ countries, providing access to 187M+ patient lives across hospitals, research organizations, and biobanks through a federated ecosystem.
• Scientific & Technology Consulting Expert guidance for evidence generation, data integration, scalable analytics, and AI implementation for life sciences organizations, including scientific consulting for study design and analysis, and technology consulting for data architecture and compliance.
• Real-World Evidence Generation End-to-end RWE solution helping life sciences teams build custom evidence networks, create bespoke datasets, and securely analyze harmonized patient-level data across the product lifecycle for clinical, regulatory, payer, medical, and commercial decisions.

Quantifiable outcome

• 80x faster processing of complex multi-modal datasets compared to traditional computing architectures
• +3 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability11 records

Feature7 records

Partnerships

Nine partnerships are on record, tiered core and supporting.

• NVIDIAcoreTechnology or Integration · 5 March 2026NVIDIA integration enables 80x faster AI-driven analytics across multi-modal health data in BC Mosaic TRE. NVIDIA GPUs, Rapids, cuDF, and cuGraph frameworks are natively available. BC Image also powered by NVIDIA CUDA for high-volume medical imaging processing.
• Amazon Web Services (AWS)coreTechnology or Integration · 3 March 2026Strategic Collaboration Agreement for AWS to accelerate healthcare and life sciences innovation. BC Mosaic TRE is available on AWS Marketplace with built-in security, NVIDIA technology integration, and deployment flexibility including European Sovereign Cloud. AWS provides the cloud infrastructure backbone for secure, scalable research environments.
• OmicsBanksupportingStrategic or Co-development Partner · 5 February 2026Strategic partnership expanding access to large-scale, research-ready longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets (India and UAE).
• MedexprimcoreStrategic or Co-development Partner · 7 December 2023Acquisition expanding BC Platforms' ability to provide global biopharma partners with secure access to Real-World clinical and imaging data across Europe. Medexprim bridges European academic hospitals and pharmaceutical companies with focus on oncology, neurology, cardiology, and rare diseases. 35 employees based in Toulouse (R&D) and Paris (commercial HQ).
• NTT (Nippon Telegraph and Telephone Corporation)coreStrategic or Co-development Partner · 19 October 2023Strategic partnership to introduce a national medical data distribution platform in Japan, integrating, curating, and harmonizing Japanese healthcare data. Brings together NTT, NTT Life Sciences Corporation, PRiME-R, and Bio-Xcelerator to advance data-driven medicine and personalized care in Japan.
• Flower LabssupportingTechnology or IntegrationPartnership enabling federated machine learning across BC Platforms' trusted research environments using the Flower Framework. Allows federated learning workflows within governed workspaces.
• Euformatics and Oncompass MedicinesupportingStrategic or Co-development PartnerPartnership selected for phase 2 of the Instand-NGS4P project to deliver standardized NGS-based oncology workflows across seven major European hospitals. BC Platforms provides data infrastructure and integration.
• Modirum Platforms, VEIL.AI, and Productivity LeapsupportingStrategic or Co-development PartnerCollaboration to publish reference architecture for Real-World Data optimized European Health Data Space (EHDS2) implementation. AI-enabled architecture automates EHDS2 data discovery, access, and secure analysis.
• HELIOS Study Partners (Singapore)supportingStrategic or Co-development PartnerSelected as partner to power data analysis for the HELIOS population health study in Singapore, advancing the nation's precision medicine programme.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ConcertAI: ConcertAI is an AI-driven oncology real-world data and evidence platform serving top pharma. Its multi-modal oncology RWD focus and EHR-grade federated architecture overlap directly with BC Platforms' BC Data/BC Mosaic offering.
• Syapse: Syapse is a real-world evidence platform focused on oncology, partnering with health systems and life sciences. Its federated health-system data network and pharma RWE delivery overlap closely with BC Platforms' data partner and RWE generation model.
• Lifebit: Lifebit provides a federated genomics and trusted research environment platform for life sciences and government. Its TRE + federated analytics architecture is structurally similar to BC Platforms' BC Mosaic offering for cross-border genomic/clinical research.
• Tempus AI: Tempus AI is an AI-powered precision medicine company that combines multi-modal clinical, genomic, and imaging data for life sciences and healthcare. It directly competes with BC Platforms' BC Catalyst/BC Data/BC Image stack for pharma evidence generation and precision medicine use cases.
• DNAnexus: DNAnexus operates a cloud-based biomedical data analysis and trusted research environment platform for clinical genomics and multi-omics studies. It competes with BC Mosaic for pharma genomics TRE workloads and large-scale biomedical data collaboration.
• COTA Healthcare: COTA Healthcare is an oncology-focused real-world data and analytics company serving life sciences. Its curated oncology RWD and evidence generation services overlap with BC Platforms' BC Data and oncology pharma use cases.

Broad incumbents

• Flatiron Health: Flatiron Health (acquired by Roche) is a major oncology real-world data and EHR provider serving life sciences and providers. It is a clear competitor in oncology RWD and clinical evidence generation, with broader hospital footprint via OncoEMR.
• Veeva Systems: Veeva Systems provides cloud software (including Vault CDB, EDC, and CTMS) for life sciences clinical and regulatory workflows. It is a broader incumbent serving pharma R&D with adjacent data management capabilities versus BC Platforms' RWD/RWE focus.
• IQVIA: IQVIA is a global leader in clinical research services and real-world evidence for life sciences. It competes with BC Platforms on enterprise pharma RWD/RWE contracts and operates a much broader services portfolio spanning clinical trials, technology, and analytics.

Emerging players

• Owkin: Owkin is an AI biotech applying federated learning to multi-modal patient data for pharma and hospitals. Its federated analytics and AI-driven biomarker discovery approach intersects with BC Catalyst and BC Mosaic capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/Bcplatforms
• LinkedInlinkedin.com/company/i-mind

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about I-Mind